Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lance B Augustin

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Endocrinology|July 1, 2006
S14: insights from knockout miceLaura T LaFave, Lance B Augustin, Cary N Mariash
Stem Cells (Dayton, Ohio)|March 19, 2002
Gene repair and transposon-mediated gene therapyPaul D Richardson, Lance B Augustin, Betsy T Kren, et al.
Oncotargets and Therapy|June 22, 2011
Antioxidant oils and Salmonella enterica Typhimurium reduce tumor in an experimental model of hepatic metastasisBrent S Sorenson, Kaysie L Banton, Lance B Augustin, et al.
Endocrinology|June 17, 2008
Hepatic expression of the SPOT 14 (S14) paralog S14-related (Mid1 interacting protein) is regulated by dietary carbohydrateNikolas G Tsatsos, Lance B Augustin, Grant W Anderson, et al.
Journal of Cancer|August 19, 2015
Vasculature Disruption Enhances Bacterial Targeting of Autochthonous TumorsJeremy J Drees, Michael J Mertensotto, Lance B Augustin, et al.
Current Microbiology|November 30, 2014
Expression of periplasmic chaperones in Salmonella Typhimurium reduces its viability in vivoMichael John Mertensotto, Jeremy J Drees, Lance B Augustin, et al.
Journal of Drug Targeting|September 4, 2020
<i>Salmonella enterica</i> Typhimurium engineered for nontoxic systemic colonization of autochthonous tumorsLance B Augustin, Liming Milbauer, Sara E Hastings, et al.
Journal of Drug Targeting|November 13, 2020
Virulence-attenuated <i>Salmonella</i> engineered to secrete immunomodulators reduce tumour growth and increase survival in an autochthonous mouse model of breast cancerLance B Augustin, Liming Milbauer, Sara E Hastings, et al.
Protein Expression and Purification|November 13, 2013
Soluble production of a biologically active single-chain antibody against murine PD-L1 in Escherichia coliJeremy J Drees, Lance B Augustin, Michael J Mertensotto, et al.
Veterinary Medicine and Science|October 26, 2017
A phase I clinical study to evaluate safety of orally administered, genetically engineered <i>Salmonella enterica</i> serovar <i>Typhimurium</i> for canine osteosarcomaSara E Fritz, Michael S Henson, Emily Greengard, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Endocrinology|July 1, 2006
S14: insights from knockout miceLaura T LaFave, Lance B Augustin, Cary N Mariash
Stem Cells (Dayton, Ohio)|March 19, 2002
Gene repair and transposon-mediated gene therapyPaul D Richardson, Lance B Augustin, Betsy T Kren, et al.
Oncotargets and Therapy|June 22, 2011
Antioxidant oils and Salmonella enterica Typhimurium reduce tumor in an experimental model of hepatic metastasisBrent S Sorenson, Kaysie L Banton, Lance B Augustin, et al.
Endocrinology|June 17, 2008
Hepatic expression of the SPOT 14 (S14) paralog S14-related (Mid1 interacting protein) is regulated by dietary carbohydrateNikolas G Tsatsos, Lance B Augustin, Grant W Anderson, et al.
Journal of Cancer|August 19, 2015
Vasculature Disruption Enhances Bacterial Targeting of Autochthonous TumorsJeremy J Drees, Michael J Mertensotto, Lance B Augustin, et al.
Current Microbiology|November 30, 2014
Expression of periplasmic chaperones in Salmonella Typhimurium reduces its viability in vivoMichael John Mertensotto, Jeremy J Drees, Lance B Augustin, et al.
Journal of Drug Targeting|September 4, 2020
<i>Salmonella enterica</i> Typhimurium engineered for nontoxic systemic colonization of autochthonous tumorsLance B Augustin, Liming Milbauer, Sara E Hastings, et al.
Journal of Drug Targeting|November 13, 2020
Virulence-attenuated <i>Salmonella</i> engineered to secrete immunomodulators reduce tumour growth and increase survival in an autochthonous mouse model of breast cancerLance B Augustin, Liming Milbauer, Sara E Hastings, et al.
Protein Expression and Purification|November 13, 2013
Soluble production of a biologically active single-chain antibody against murine PD-L1 in Escherichia coliJeremy J Drees, Lance B Augustin, Michael J Mertensotto, et al.
Veterinary Medicine and Science|October 26, 2017
A phase I clinical study to evaluate safety of orally administered, genetically engineered <i>Salmonella enterica</i> serovar <i>Typhimurium</i> for canine osteosarcomaSara E Fritz, Michael S Henson, Emily Greengard, et al.
Pageof 1